Zobrazeno 1 - 10
of 120
pro vyhledávání: '"H L Greene"'
Autor:
Floden L, Mateski D, H L Greene, Eleanor Schron, Prasun M, Michael A. Brodsky, Holmes D, Constantine M, Chung M, Thomas P. Rocco, Sheppard R, Lader E, Lynn Shemanski, Jenkins Ls
Publikováno v:
American Heart Journal. 149:112-120
Objective The objective of this prespecified substudy of the AFFIRM study, in which no differences in survival or event rates were found in patients with atrial fibrillation (AF) randomized to either rate control or rhythm control, was to test the nu
Autor:
E. B. Schron, S. Boczor, Dean Follmann, Riccardo Cappato, Michael J. Domanski, H L Greene, Michael Gent, A. P. Hallstrom, K.-H. Kuck, Stuart J. Connolly, D. P. Zipes, Robin S. Roberts
Publikováno v:
European Heart Journal. 21:2071-2078
Aims Three randomized trials of implantable cardioverter defibrillator (ICD) therapy vs medical treatment for the prevention of death in survivors of ventricular fibrillation or sustained ventricular tachycardia have been reported with what might app
Autor:
J M Kammerling, Mark D. Carlson, Henry J. Duff, Donald W. Romhilt, Jeffrey L. Anderson, Ross A. Davies, M Huther, H. L. Greene, Al Hallstrom
Publikováno v:
American Heart Journal. 130:71-79
In this study we investigated the time to the first arrhythmic, ischemic, or failure event for encainide-flecainide and moricizine versus their respective placebo comparison groups in the Cardiac Arrhythmia Suppression Trial. The purpose was to explo
Publikováno v:
Annual Review of Nutrition. 13:83-109
INTRODUCTION . TYPE I GLYCOGEN STORAGE DISEASE . Blood Glucose Changes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Lactic Acid Changes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Hyperlipide
Autor:
J N, Udall, H L, Greene
Publikováno v:
Pediatrics in Review. 13:185-194
Publikováno v:
Statistics in Medicine. 10:1621-1631
An example from the Cardiac Arrhythmia Suppression Trial (CAST) illustrates what we term the ‘healthy responder’ phenomenon. The hypothesis is that patients who respond to a given treatment are healthier than patients who do not respond. In obser
Autor:
Gust H. Bardy, George Johnson, S Feldman, Rahul Mehra, Tom D. Ivey, H L Greene, Margaret D. Allen
Publikováno v:
Circulation. 81:1252-1259
A consistently effective transvenous defibrillation system for use in automatic defibrillators could significantly alter the approach to patients at risk of sudden death. Transvenous defibrillation systems that use a right ventricular (RV) electrode
Autor:
Joyce C Kellen, H L Greene, Bernard J. Gersh, Eleanor Schron, Scott D. Corley, Lynn Shemanski, Affirm Investigators, Anne B. Curtis, D. G. Wyse, Yves Rosenberg, John P. DiMarco, Michael J. Domanski, Albert L. Waldo, Mary Mickel, Joy Dalquist Nelson, Nancy L. Geller
Publikováno v:
American heart journal. 149(4)
BACKGROUND The AFFIRM Study was a randomized multicenter comparison of 2 treatment strategies, rate-control versus rhythm-control, in high-risk patients with atrial fibrillation (AF). The primary outcome of the trial showed no overall difference in s
Autor:
Albert L. Waldo, Joyce C Kellen, Eleanor Schron, D. G. Wyse, M C Mickel, Michael J. Domanski, J E Dalquist, H L Greene, Yves Rosenberg, John P. DiMarco, Scott D. Corley
Publikováno v:
The New England journal of medicine. 347(23)
Background There are two approaches to the treatment of atrial fibrillation: one is cardioversion and treatment with antiarrhythmic drugs to maintain sinus rhythm, and the other is the use of rate-controlling drugs, allowing atrial fibrillation to pe
Autor:
H L, Greene
Publikováno v:
Health news (Waltham, Mass.). 7(6)